Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China
- PMID: 17846128
- PMCID: PMC2167975
- DOI: 10.1128/AAC.00416-07
Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China
Abstract
Seventy-four Mycobacterium tuberculosis clinical isolates from China were subjected to drug susceptibility testing using ethambutol, isoniazid, rifampin, and ofloxacin. The results revealed that the presence of embB mutations did not correlate with ethambutol resistance but was associated with multiple-drug resistance, especially resistance to both ethambutol and rifampin.
Figures
References
-
- Chan, E. D., D. Chatterjee, M. D. Iseman, and L. B. Heifets. 2004. Pyrazinamide, ethambutol, ethionamide, and aminoglycosides, p. 778. In W. N. Rom and S. M. Garay (ed.), Tuberculosis, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, PA.
-
- Hazbon, M. H., M. Bobadilla del Valle, M. I. Guerrero, M. Varma-Basil, I. Filliol, M. Cavatore, R. Colangeli, H. Safi, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, A. Davidow, M. Brimacombe, C. I. Leon, T. Porras, M. Bose, F. Chaves, K. D. Eisenach, J. Sifuentes-Osornio, A. Ponce de Leon, M. D. Cave, and D. Alland. 2005. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49:3794-3802. - PMC - PubMed
-
- Mazars, E., S. Lesjean, A. L. Banuls, M. Gilbert, V. Vincent, B. Gicquel, M. Tibayrenc, C. Locht, and P. Supply. 2001. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc. Natl. Acad. Sci. USA 98:1901-1906. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
